| Literature DB >> 35897934 |
Elena Petricci1, Simone Zurzolo1, Camilla Matassini2, Samuele Maramai1, Francesca Cardona2, Andrea Goti2, Maurizio Taddei1.
Abstract
A general method for the synthesis of pyrrolizidine derivatives using an intramolecular hydroaminomethylation protocol (HAM) under microwave (MW) dielectric heating is reported. Starting from a 3,4-bis(benzyloxy)-2-[(benzyloxy)methyl]-5-vinylpyrrolidine, MW-assisted intramolecular HAM in the presence of gaseous H2 and CO gave the natural alkaloid hyacinthacine A2 protected as benzyl ether. The same approach gave a lentiginosine analogue starting from the corresponding vinyl N-hydroxypyrrolidine. The nature of the reaction products and the yields were strongly influenced by the relative stereochemistry of the starting pyrrolidines, as well as by the catalyst/ligand employed. The use of ethanol as a solvent provides environmentally friendly conditions, while the ligand/catalyst system can be recovered by separating the alkaloid product with an SCX column and recycling the ethanolic solution. HAM worked up to three times with the recycled catalyst solution without any significant impact on yield.Entities:
Keywords: hydroaminomethylation; hydroformylation; microwave-assisted organic synthesis; pyrrolizidine alkaloid
Mesh:
Substances:
Year: 2022 PMID: 35897934 PMCID: PMC9332719 DOI: 10.3390/molecules27154762
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Representative biologically active natural pyrrolizidine alkaloids and analogues of indolizidine ones.
Scheme 1Different approaches to the synthesis of pyrrolizidine alkaloids starting from nitrones of general structures A and B.
Scheme 2(A). Retrosynthesis for target pyrrolizidines. (B). A putative mechanism of the HAM approach.
Scheme 3HAM of hydroxylamine 7 and amine 9.
HAM optimisation for the synthesis of nor-lentiginosine.
| En | SM | Conditions [a] | Rec SM (%) | 10 | 11 | 12 | 13 | 8 |
|---|---|---|---|---|---|---|---|---|
| 1 |
| CO/H2 (7 bar), Xantphos/(PPh3)3Rh(CO)H, Toluene/[bmim][BF4], MW, 110 °C, 30 min | 19 | 44 | 5 | 10 | - | - |
| 2 |
| 70 | - | 27 | - | - | - | |
| 3 |
| CO/H2 (7 bar), Xantphos/(PPh3)3Rh(CO)H EtOH, MW, 110 °C, 30 min | 12 | - | - | 5 | - | 65 |
| 4 |
| 72 | 5 | 20 | - | - | - | |
| 5 |
| CO/H2 (7 bar), Xantphos/(PPh3)3Rh(CO)H Toluene, MW, 80 °C, 30 min | 88 | - | - | - | - | - |
| 6 |
| 22 | - | - | - | 74 | - | |
| 7 |
| CO/H2 (7 bar), Xantphos/(PPh3)3Rh(CO)H Toluene/[bmim][BF4], MW, 130 °C, 30 min | 54 | 10 | 20 | 10 | - | - |
| 8 |
| 63 | - | 27 | 2 | 5 | - | |
| 9 |
| CO/H2 (7 bar), Biphephos/(PPh3)3Rh(CO)H EtOH, MW, 110 °C, 30 min | - | - | - | - | 99 | - |
| 10 |
| 2 | - | - | - | 90 | - | |
| 11 |
| CO/H2 (7 bar), PPh3/(PPh3)3Rh(CO)H, EtOH, MW, 110 °C, 30 min | 67 | - | - | - | 31 | - |
| 12 |
| 5 | - | - | - | 92 | - | |
| 13 |
| CO/H2 (7 bar), PPh3/(PPh3)3Rh(CO)H Toluene, MW, 80 °C, 30 min | 55 | - | - | - | - | 38 |
| 14 |
| CO/H2 (7 bar), Biphephos/[RhCl(COD)]2 EtOH, MW, 110 °C, 30 min | 32 | - | 15 | 5 | 32 | 10 |
[a] all reactions are performed by setting the specific temperature required for the experiment and by setting at 150 Watt the maximum power to be used to reach the expected temperature.
Scheme 4Synthesis of nor-lentiginosine 3.
Scheme 5HAM of 14.
HAM optimisation for Hyacintacine A2 synthesis.
| En | SM | Conditions | Rec SM | 18 | 20 | 21 | 22 |
|---|---|---|---|---|---|---|---|
| 1 |
| Xantphos, Toluene, [bmim][BF4], | 74% | 28% [a] | - | - | |
| 2 |
| Xantphos, Toluene, [bmim][BF4], | 56% | 5% [a] | - | 2% | 27% |
| 3 |
| Xantphos, EtOH, MW, 110 °C, 30 min | 99% | - | - | - | - |
| 4 |
| Biphephos, EtOH, MW, 110 °C, | - | 96% [a] | - | - | - |
| 5 |
| Xantphos, Toluene, [bmim][BF4], | 42% | - | 43% | - | |
| 6 |
| Xantphos, Toluene, [bmim][BF4], | 42% | - | 10% | 10% | 20% |
| 7 |
| Xantphos, EtOH, 110 °C, 30 min | - | 5% [b] | - | - | 82% |
| 8 |
| Biphephos, EtOH, 110 °C, 30 min | - | 99% [b] | - | - | - |
| 9 |
| PPh3, EtOH, 110 °C, 30 min | 31% | 57% [b] | - | - | - |
[a] 18a; [b] 18b.
Scheme 6HAM for the synthesis of Hyacintacine A2.